Thursday, 22 May 2014

Berlin BIO-TIC Workshop: Use of IB in Bio-Surfactants

BIO-TIC is organising a ‘bio-business workshop’ on the use of industrial biotechnology (IB) in bio-surfactants on 3 September 2014 in Berlin. This will be the first of a series of five workshops looking at product segments and applications in the bioeconomy that BIO-TIC have identified as having significant potential for boosting the competitiveness of European industry and benefiting society by 2030.

The workshop will take place on 3 September at the Westin Grand Hotel, Berlin and will precede the Third ICIS European Surfactants Conference as a satellite event. Registration will be opening soon.

The objectives of the workshop are to:
  • identify technological, non-technological and market hurdles for the uptake of industrial biotechnology in bio-surfactants
  • develop recommendations and solutions to overcome the identified hurdles 
  • contribute to the development, testing and fine-tuning of the BIO-TIC roadmaps 
  • bring together industrial biotechnology end users (downstream) with technology providers (upstream), innovation agencies and decision makers to stimulate interconnected discussion and knowledge exchange platforms and processes
  • collect data to develop draft indicators to measure the socio-economic and environmental impact of IB and the use of renewables-based products in the European Union. 
Why attend the workshop?
Input from the market and experts in industry and research are vital to build a basis for BIO-TIC’s roadmaps. Therefore, the BIO-TIC team is working to engage with multiple stakeholders across different value chains with activities on a range of technological domains from chemistry and engineering to health and the environment.

The idea is to share knowledge with experts and receive recommendations. BIO-TIC has organised a series of “bio-workshops” across Europe, which started in June 2013 and will continue to the end of 2014. The initial workshops were held at a regional level and addressed all business cases. In 2014, BIO-TIC is holding one workshop per business case at a European level. All bio-business workshops will be announced on the BIO-TIC website.

As the bio-surfactants workshop will precede the 3rd ICIS European Surfactants Conference this means that major experts will already be there, increasing the effectiveness and the participation in the workshop and the benefits of attending both events.

Attendance at the workshop will be free of charge but prior registration via the BIO-TIC website will be required. Details of registration will be announced soon on the BIO-TIC website.

For more information on the BIO-TIC bio-surfactants workshop download the workshop flyer or contact the BIO-TIC secretariat.

More details on the 3rd ICIS European Surfactants Conference: - Understanding the key market drivers, trends, challenges and regulations impacting the region’ that takes place on 4 and 5 September can be found on the conference website. You can download a brochure for the ICIS event here.

What is BIO-TIC?
Funded by the European Commission, BIO-TIC was launched, as an FP7 project, with the aim to establish an overview of the opportunities and barriers to biotechnology innovation and propose approaches to address them.

Modern use of industrial biotechnology (IB) is critical in a bio-based economy. Deploying the full potential of biotech innovation will enable the European industry to deliver high-value products to consumers and create new commercial opportunities. New feedstock demands will lead to synergies amongst SMEs and large industrial partners. New technological developments will boost European export of technology and facilities by bringing some of Europe’s top sectors together: chemical industry, engineering and renewables.

However to date, major hurdles continue to hamper the full exploitation of biotechnology in Europe. These hurdles may vary from technological bottlenecks to limited availability of venture capital and fragmented policy frameworks.

BIO-TIC seeks to define product segments and applications that promise significant potential for Europe’s industry and society by 2030. We have now identified five major “bio-business cases” which are EU-competitive and have the potential to introduce cross-cutting technology ideas.

These are:
  • Bio-plastics PHA (polyhydroxyalkanoates) and PLA (polylactic acid)
  • Building blocks 
  • Bio-fuels 
  • Bio-surfactants 
  • CO2-based chemicals 
Based on these business cases, we are developing three in-depth “bio-roadmaps”. These will focus on the market potential, R&D priorities and non-technological hurdles of IB innovation. In particular, the market roadmap will provide market projections upto 2030. The technology roadmap will focus on setting R&D priorities and identifying needs for pilot and demonstration of plant activities. Last but not least, the non-technological barriers roadmap will identify regulatory and non-technological hurdles that may inhibit industrial biotech innovation reaching new market opportunities. The second draft version of the roadmaps is already online while the final version will be released in July 2015.

All BIO-TIC roadmaps, can be downloaded from our Partnering Platform. For more information about the BIO-TIC FP7 project visit our website.

No comments:

Post a Comment

Please post your comment here. Please note that this newsblog is not moderated.